Sam Brusco, Associate Editor04.24.24
CONMED Corporation has promoted its president of international and global orthopedics Patrick Beyer to the newly created role of chief operating officer (COO), effective immediately.
In this role, Beyer will lead the company’s commercial businesses, as well as operations, operations, distribution, regulatory affairs/quality assurance, and customer excellence.
Beyer joined CONMED in 2014 as president of international. In 2020, he was promoted to president of international and global orthopedics, where he accepted the responsibilities for the company’s global orthopedics R&D and U.S. orthopedics commercial business.
In 2022, Beyer led the process of acquiring both In2Bones and BioRez. He also spent 21 years at Stryker in increasing leadership roles and almost four years as CEO of ICNet International.
“Pat has been invaluable in driving CONMED’s above-market growth and expanding our presence in key markets,” said Curt R. Hartman, CONMED’s board chair, president, and CEO. “He is an experienced leader with a proven track record of commercial and operational excellence and delivering results, and I look forward to Pat’s continued impact on the organization.”
“I am excited to take on this important leadership role at CONMED and to continue contributing to the Company’s innovation and success,” said Beyer. “I look forward to continuing to work with the team to build on CONMED’s legacy of delivering high-quality products and creating value for physicians and patients around the world.”
In this role, Beyer will lead the company’s commercial businesses, as well as operations, operations, distribution, regulatory affairs/quality assurance, and customer excellence.
Beyer joined CONMED in 2014 as president of international. In 2020, he was promoted to president of international and global orthopedics, where he accepted the responsibilities for the company’s global orthopedics R&D and U.S. orthopedics commercial business.
In 2022, Beyer led the process of acquiring both In2Bones and BioRez. He also spent 21 years at Stryker in increasing leadership roles and almost four years as CEO of ICNet International.
“Pat has been invaluable in driving CONMED’s above-market growth and expanding our presence in key markets,” said Curt R. Hartman, CONMED’s board chair, president, and CEO. “He is an experienced leader with a proven track record of commercial and operational excellence and delivering results, and I look forward to Pat’s continued impact on the organization.”
“I am excited to take on this important leadership role at CONMED and to continue contributing to the Company’s innovation and success,” said Beyer. “I look forward to continuing to work with the team to build on CONMED’s legacy of delivering high-quality products and creating value for physicians and patients around the world.”